BUY SBI Life Insurance Company Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)3 Nov 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
SBI Life stock: Nomura keeps Buy as target falls to Rs 2,340
NewsGoogle News·31 Oct · 1w ago
SBI Life Insurance Q2 FY27: net profit up 10.9% YoY to ₹549 Cr as net premium income rises to ₹26,877 Cr
NewsGoogle News·28 Oct · 1w ago
SBI Life shares rise 2% despite Q2 profit missing estimates; Brokerages retain Buy call
NewsGoogle News·28 Oct · 1w ago
Earnings call transcript: SBI Life posts strong H1 2027 growth as stock slips 0.65%
NewsGoogle News·27 Oct · 1w ago
SBI Life Insurance reported financial results for the quarter and half-year ended September 30, 2026, showing a 17% growth in Profit After Tax to ₹12.7 billion and a 19% growth in Value of New Busines
NSE · Press Release·27 Oct · 1w ago
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·6 Nov · yesterday
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on SBI Life Insurance Company
- BUY — Rajesh Satpute5 Nov 2026 · Same day · target ₹1,760 · Expired
- BUY — Sahaj Agrawal, Kotak Securities4 Nov 2026 · ~2 weeks · target ₹1,790 · Active
- BUY — Sahaj Agrawal, Kotak Securities4 Nov 2026 · ~2 weeks · target ₹1,750 · Target hit
- BUY — Jigar S Patel, Anand Rathi29 Oct 2026 · ~2 weeks · target ₹1,775 · Target hit
- BUY — Mehul Kothari, Anand Rathi28 Oct 2026 · ~1 year · target ₹1,800 · Active
More from ICICI Securities
- BUY ICICI Bank5 Nov 2026 · ~1 year · target ₹1,800 · Active
- BUY Stylam Industries5 Nov 2026 · ~1 year · target ₹3,750 · Active
- BUY Emcure Pharmaceuticals5 Nov 2026 · ~1 year · target ₹2,560 · Active
- BUY Saregama India5 Nov 2026 · ~1 year · target ₹740 · Active
- BUY Procter & Gamble Health4 Nov 2026 · ~1 year · target ₹6,680 · Active

